The Business Roundtable, led by Jamie Dimon, gives a new definition of the "purpose of a corporation."Marketsread more
Stocks rose sharply on Monday as Treasury yields rebounded, quelling fears of a possible recessionUS Marketsread more
Powell will have the opportunity if not to walk back the "mid-cycle" assessment then to at least provide some further explanation about what it means.Economyread more
J.P. Morgan estimates the average annual tariff cost per household will be $1,000 with the new round of Trump's tariffs.Marketsread more
Since its IPO 15 years ago, Google has become more and more powerful. Today, that power is being highly scrutinized.Technologyread more
Sequoia's Michael Moritz says that direct listings worked for Spotify and Slack and will become more common for companies with "courage and intelligence."Technologyread more
Shares of embattled utility PG&E plummeted after a judge ruled that a jury can decided whether it should pay up to $18 billion in damages.Marketsread more
The attacks come after state and local ransomware attacks in New York, Louisiana, Maryland and Florida resulted in the loss of significant sums.Technologyread more
In a statement Monday, Barr named Kathleen Hawk Sawyer the new director of the Federal Bureau of Prisons.Politicsread more
A strong jobs market and tax cuts are helping to bolster consumer spending at restaurants. The National Restaurant Association projects overall industry sales will hit a high...Restaurantsread more
Lobbying disclosure reports show that Maria Ressa, who founded news website Rappler Inc. in the Philippines, has tapped two partners out of Covington & Burling to help her...Politicsread more
Pharmacy reimbursement rates challenged Rite Aid earnings in the latest quarter, Chairman and CEO John Standley said, in a statement.
Rite Aid shares slipped more than 1 percent Thursday after releasing its first-quarter results. The stock ended the day slightly lower.
The drugstore chain reported adjusted quarterly earnings at 1 cent per share, below a Reuters estimate of 5 cents a share. Revenue rose 23 percent to $8.2 billion on a year-over-year basis, but came in below a forecast of $8.26 billion.
Standley said the chain wasn't able to offset the rate pressure through drug purchasing efficiencies.
"While drug cost reductions will continue to be short of our expectations in the near term, we anticipate improvements over the second half of the fiscal year. As we work to meet this challenge, we remain focused on executing our highly successful sales initiatives like wellness+ with Plenti and the Wellness store program while also making strategic investments for growth and delivering a consistently outstanding customer experience," he said in a statement.
Shares of Rite Aid jumped last week after a report said there are growing signs that the Federal Trade Commission will approve Walgreens' $17 billion acquisition of Rite Aid. The two drugstores agreed to merge in February 2015.
Rite Aid said it expects to close deal with Walgreens Boots Alliance in the second half of this year.
Rite Aid's stock is just slightly lower so far this year.
RAD 2016 Chart